The C-terminal antibody binding domain of Candida albicans mp58 represents a protective epitope during candidiasis

FEMS Microbiology Letters

Volumn 232, Issue 2, 2004, Pages 133-138

  Viudes, Angel ^a   Lazzell, Anna ^a   Perea, Sofia ^a   Kirkpatrick, William R ^a   Peman, Javier ^b   Patterson, Thomas F ^a   Martinez, Jose P ^c   López Ribot, José L ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

^c UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Candida albicans; Monoclonal antibody; Protective epitope

Indexed keywords

EPITOPE;

AMINO TERMINAL SEQUENCE; ANTIBODY RESPONSE; ANTIGEN BINDING; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CARBOXY TERMINAL SEQUENCE; EPITOPE MAPPING; HUMAN; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROTECTION; PROTEIN DOMAIN;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; CANDIDA ALBICANS; CANDIDIASIS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; EPITOPES; FEMALE; FUNGAL PROTEINS; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED BALB C; PROTEIN STRUCTURE, TERTIARY;

ANIMALIA; CANDIDA; CANDIDA ALBICANS; MURINAE;

EID: 1842472031     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(04)00042-4     Document Type: Article

References (22)

1. Eggimann P., Garbino J., Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect. Dis. 3:2003;685-702.
2. Viudes A., Peman J., Canton E., Ubeda P., Lopez-Ribot J.L., Gobernado M. Candidemia at a tertiary-care hospital: epidemiology, treatment, clinical outcome and risk factors for death. Eur. J. Clin. Microbiol. Infect. Dis. 21:2002;767-774.
3. Chaffin W.L., Lopez-Ribot J.L., Casanova M., Gozalbo D., Martinez J.P. Cell wall and secreted proteins of Candida albicans: identification, function, and expression. Microbiol. Mol. Biol. Rev. 62:1998;130-180.
4. Martinez J.P., Gil M.L., Lopez-Ribot J.L., Chaffin W.L. Serologic response to cell wall mannoproteins and proteins of Candida albicans. Clin. Microbiol. Rev. 11:1998;121-141.
5. Casadevall A. Antibody immunity and invasive fungal infections. Infect. Immun. 63:1995;4211-4218.
6. Casadevall A., Cassone A., Bistoni F., Cutler J.E., Magliani W., Murphy J.W., Polonelli L., Romani L. Antibody and/or cell-mediated immunity, protective mechanisms in fungal disease: an ongoing dilemma or an unnecessary dispute? Med. Mycol. 36:1998;95-105.
7. Casadevall A., Feldmesser M., Pirofski L.A. Induced humoral immunity and vaccination against major human fungal pathogens. Curr. Opin. Microbiol. 5:2002;386-391.
8. Polonelli L., et al. The efficacy of acquired humoral and cellular immunity in the prevention and therapy of experimental fungal infections. Med. Mycol. 38:2000;281-292.
9. Tavares D., Ferreira P., Vilanova M., Videira A., Arala-Chaves M. Immunoprotection against systemic candidiasis in mice. Int. Immunol. 7:1995;785-796.
10. van Deventer H.J., Goessens W.H., van Vliet A.J., Verbrugh H.A. Anti-enolase antibodies partially protective against systemic candidiasis in mice. Clin. Microbiol. Infect. 2:1996;36-43.
11. Polonelli L., Seguy N., Conti S., Gerloni M., Bertolotti D., Cantelli C., Magliani W., Cailliez J.C. Monoclonal yeast killer toxin-like candidacidal anti-idiotypic antibodies. Clin. Diagn. Lab. Immunol. 4:1997;142-146.
12. Moragues M.D., Omaetxebarria M.J., Elguezabal N., Sevilla M.J., Conti S., Polonelli L., Ponton J. A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C. albicans activities. Infect. Immun. 71:2003;5273-5279.
13. Han Y., Cutler J.E. Antibody response that protects against disseminated candidiasis. Infect. Immun. 63:1995;2714-2719.
14. Matthews R.C., Rigg G., Hodgetts S., Carter T., Chapman C., Gregory C., Illidge C., Burnie J. Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90. Antimicrob. Agents Chemother. 47:2003;2208-2216.
15. Casanova M., Lopez-Ribot J.L., Monteagudo C., Llombart-Bosch A., Sentandreu R., Martinez J.P. Identification of a 58-kilodalton cell surface fibrinogen-binding mannoprotein from Candida albicans. Infect. Immun. 60:1992;4221-4229.
16. Lopez-Ribot J.L., Monteagudo C., Sepulveda P., Casanova M., Martinez J.P., Chaffin W.L. Expression of the fibrinogen binding mannoprotein and the laminin receptor of Candida albicans in vitro and in infected tissues. FEMS Microbiol. Lett. 142:1996;117-122.
17. Lopez-Ribot J.L., Sepulveda P., Cervera A.M., Roig P., Gozalbo D., Martinez J.P. Cloning of a cDNA fragment encoding part of the protein moiety of the 58-kDa fibrinogen-binding mannoprotein of Candida albicans. FEMS Microbiol. Lett. 157:1997;273-278.
18. Lopez-Ribot J.L., McAtee R.K., Kirkpatrick W.R., La Valle R., Patterson T.F. Low levels of antigenic variability in fluconazole-susceptible and -resistant Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Clin. Diagn. Lab. Immunol. 6:1999;665-670.
19. Viudes A., Perea S., Lopez-Ribot J.L. Identification of continuous B-cell epitopes on the protein moiety of the 58-kiloDalton cell wall mannoprotein of Candida albicans belonging to a family of immunodominant fungal antigens. Infect. Immun. 69:2001;2909-2919.
20. Lopez-Ribot J.L., McAtee R.K., Lee L.N., Kirkpatrick W.R., White T.C., Sanglard D., Patterson T.F. Distinct patterns of gene expression associated with development of fluconazole resistance in serial Candida albicans isolates from human immunodeficiency virus-infected patients with oropharyngeal candidiasis. Antimicrob. Agents Chemother. 42:1998;2932-2937.
21. Lee K.L., Buckley H.R., Campbell C.C. An amino acid liquid synthetic medium for the development of mycelial and yeast forms of Candida Albicans. Sabouraudia. 13:1975;148-153.
22. Ponton, J., Moragues, M.D. and Quindos, G. (2002) Laboratory work up of candidiasis: Non-culture-based diagnostics. In: Candida and Candidiasis (Calderone, R.A., Ed.), pp. 395-425. ASM Press, Washington, DC.